| 1 |
34637110 | Cisplatin-based Electrochemotherapy Significantly Downregulates Key Heat Shock Proteins in MDA-MB-231-Human Triple-Negative Breast Cancer Cells. | 2022 Jan |
1 |
| 2 |
35190872 | Hsp90 inhibition sensitizes DLBCL cells to cisplatin. | 2022 Apr |
3 |
| 3 |
33331136 | HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer. | 2021 Apr |
3 |
| 4 |
33738259 | Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling. | 2021 |
3 |
| 5 |
34585447 | Zeylenone synergizes with cisplatin in osteosarcoma by enhancing DNA damage, apoptosis, and necrosis via the Hsp90/AKT/GSK3β and Fanconi anaemia pathway. | 2021 Oct |
2 |
| 6 |
34944784 | HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. | 2021 Dec 7 |
2 |
| 7 |
32608202 | Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells. | 2020 Jul |
2 |
| 8 |
33102211 | Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib. | 2020 |
6 |
| 9 |
33167494 | Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. | 2020 Nov 5 |
2 |
| 10 |
30925862 | PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma. | 2019 Mar 29 |
2 |
| 11 |
31449053 | Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation. | 2019 Oct 1 |
1 |
| 12 |
29331417 | Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma. | 2018 Apr 1 |
1 |
| 13 |
30153855 | HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. | 2018 Aug 28 |
1 |
| 14 |
27887849 | Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluoro-phenylamino)-4H-1,3-thiazine[6,5-b]indole in A2780cis cells. | 2017 Jan |
1 |
| 15 |
28288818 | 3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways. | 2017 Jul 1 |
1 |
| 16 |
26481477 | Membrane-bound heat shock proteins facilitate the uptake of dying cells and cross-presentation of cellular antigen. | 2016 Jan |
1 |
| 17 |
25333998 | Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells. | 2015 Jan |
2 |
| 18 |
26221207 | Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells. | 2015 |
2 |
| 19 |
26517240 | Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition. | 2015 Dec 29 |
2 |
| 20 |
24317439 | The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway. | 2014 Feb |
4 |
| 21 |
23135731 | Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells. | 2013 Jan |
5 |
| 22 |
23561390 | Re: potential role of hsp90 inhibitors in overcoming Cisplatin resistance of bladder cancer-initiating cells. | 2013 Apr |
1 |
| 23 |
21864883 | Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions. | 2012 Apr |
3 |
| 24 |
21964864 | Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. | 2012 Aug 15 |
6 |
| 25 |
22537224 | Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin. | 2012 Apr 26 |
4 |
| 26 |
20883729 | HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion. | 2011 Jan |
1 |
| 27 |
21645448 | [The correlation between the up-regulation of Hsp90 and drug resistance to cisplatin in lung cancer cell line]. | 2011 Jun |
4 |
| 28 |
18992762 | The dimethylthiourea-induced attenuation of cisplatin nephrotoxicity is associated with the augmented induction of heat shock proteins. | 2009 Jan 15 |
1 |
| 29 |
19578756 | Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses. | 2009 Aug |
1 |
| 30 |
19740745 | A truncated form of p23 down-regulates telomerase activity via disruption of Hsp90 function. | 2009 Nov 6 |
1 |
| 31 |
18279962 | Defining targets of modulation of human tumor cell response to cisplatin. | 2008 Jul |
1 |
| 32 |
18955054 | Cisplatin differently affects amino terminal and carboxyl terminal domains of HSP90. | 2008 Nov 26 |
6 |
| 33 |
17319785 | Hsp90 inhibitor geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin. | 2007 |
1 |
| 34 |
21122290 | [Different proteome of human lung adenocarcinoma cells treated with NS-398 and cisplation]. | 2007 Aug 20 |
1 |
| 35 |
17073714 | Effectiveness of hsp90 inhibitors as anti-cancer drugs. | 2006 Oct |
1 |
| 36 |
15455381 | Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin. | 2005 Jan 10 |
1 |
| 37 |
16273226 | Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin. | 2005 Dec |
3 |
| 38 |
15378690 | A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. | 2004 Oct |
1 |
| 39 |
12842893 | Hsp90 inhibition accelerates cell lysis. Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide- and Hsp90-dependent events. | 2003 Sep 12 |
1 |
| 40 |
12869591 | The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation. | 2003 Oct |
5 |
| 41 |
11751878 | A Nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket. | 2002 Mar 1 |
3 |
| 42 |
12415202 | Heat-shock protein 90: potential involvement in the pathogenesis of malignancy and pharmacological intervention. | 2002 Oct |
1 |